Thorne Healthtech, Inc. Common Stock
THRN
THRN was delisted on the 13th of October, 2023.
0 hedge funds and large institutions have $0 invested in Thorne Healthtech, Inc. Common Stock in 2023 Q4 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 59 closing their positions.
15.01% less ownership
Funds ownership: 15.01% → 0% (-15%)
100% less funds holding
Funds holding: 59 → 0 (-59)
100% less capital invested
Capital invested by funds: $82.9M → $0 (-$82.9M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 59
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCL
Glazer Capital LLC
New York
|
-$13.6M |
| 2 |
Vanguard Group
Malvern,
Pennsylvania
|
-$8.77M |
| 3 |
GF
Gabelli Funds
Rye,
New York
|
-$8.52M |
| 4 |
BlackRock
New York
|
-$7.47M |
| 5 |
BCM
Beryl Capital Management
Redondo Beach,
California
|
-$6.36M |
THRN Hedge Fund Activity: Q4 2023 in Review
0 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in Thorne Healthtech, Inc. Common Stock (THRN) for Q4 2023, worth a combined $0 — down 100% from $82.9M a quarter earlier.
Sellers outnumbered buyers: 59 funds closed out of THRN and 0 opened new positions — a net loss of 59 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Glazer Capital LLC, exiting entirely with an estimated $13.6M sold.
- 0 institutional investors held Thorne Healthtech, Inc. Common Stock (THRN) as of Q4 2023, down from 59 in Q3 2023.
- Funds reported $0 of Thorne Healthtech, Inc. Common Stock stock for Q4 2023, down 100% quarter-over-quarter.
- 0 funds opened new Thorne Healthtech, Inc. Common Stock positions in Q4 2023 and 59 closed out, a net change of -59 holders.
- The largest Thorne Healthtech, Inc. Common Stock seller in Q4 2023 was Glazer Capital LLC, an estimated $13.6M sold.
Based on aggregated 13F filings for Q4 2023.